{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T13:21:01Z","timestamp":1758979261887,"version":"3.44.0"},"reference-count":17,"publisher":"Elsevier BV","issue":"6-7","license":[{"start":{"date-parts":[[2010,6,1]],"date-time":"2010-06-01T00:00:00Z","timestamp":1275350400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,6,1]],"date-time":"2010-06-01T00:00:00Z","timestamp":1275350400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annales de Dermatologie et de V\u00e9n\u00e9r\u00e9ologie"],"published-print":{"date-parts":[[2010,6]]},"DOI":"10.1016\/j.annder.2010.04.008","type":"journal-article","created":{"date-parts":[[2010,6,9]],"date-time":"2010-06-09T04:50:19Z","timestamp":1276059019000},"page":"437-443","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Pertinence des crit\u00e8res diagnostiques de tuberculose latente avant traitement du psoriasis par anti-TNF-alpha"],"prefix":"10.1016","volume":"137","author":[{"given":"C.","family":"Goujon","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Gormand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Gunera-Saad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Dahel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Vial","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.-F.","family":"Nicolas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.annder.2010.04.008_bib1","unstructured":"Agence fran\u00e7aise de s\u00e9curit\u00e9 sanitaire des produits de sant\u00e9. Recommandation nationales\u00a0: pr\u00e9vention et prise en charge des tuberculoses survenant sous anti-TNF alpha (juillet 2005). www.afssaps.sante.fr."},{"key":"10.1016\/j.annder.2010.04.008_bib2","first-page":"10","article-title":"L\u2019intradermo-r\u00e9action a la tuberculine et son interpr\u00e9tation clinique","volume":"18","author":"Mantoux","year":"1910","journal-title":"Presse Med"},{"key":"10.1016\/j.annder.2010.04.008_bib3","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1016\/j.arcped.2005.09.017","article-title":"Enqu\u00eate sur les pratiques actuelles et futures du vaccin contre la tuberculose aupr\u00e8s des p\u00e9diatres et g\u00e9n\u00e9ralistes en France","volume":"12","author":"de la Rocque","year":"2005","journal-title":"Arch Pediatr"},{"key":"10.1016\/j.annder.2010.04.008_bib4","doi-asserted-by":"crossref","unstructured":"Recommandations de la soci\u00e9t\u00e9 de pneumologie de langue fran\u00e7aise sur la prise en charge de la tuberculose en France (texte court). Conf\u00e9rence d\u2019experts. Rev Mal Respir 2004;21:414\u201320.","DOI":"10.1016\/S0761-8425(04)71306-6"},{"key":"10.1016\/j.annder.2010.04.008_bib5","doi-asserted-by":"crossref","first-page":"385","DOI":"10.4414\/fms.2006.05842","article-title":"Diagnostic de l\u2019infection latente \u00e0 Mycobacterium tuberculosis\u00a0: raisons pour lesquelles le test \u00e0 la tuberculine est obsol\u00e8te et quels tests le remplacent","volume":"6","author":"Gadola","year":"2006","journal-title":"Forum Med Suisse"},{"key":"10.1016\/j.annder.2010.04.008_bib6","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.arcped.2006.11.008","article-title":"Avantages et limites des tests sanguins in vitro lymphocytes T\/interf\u00e9ron gamma comparativement au test intradermique \u00e0 la tuberculine pour le diagnostic de tuberculose","volume":"14","author":"Herrmann","year":"2007","journal-title":"Arch Pediatr"},{"key":"10.1016\/j.annder.2010.04.008_bib7","unstructured":"Centers for Disease Control and Prevention. Essential components of a tuberculosis prevention and control program: screening for tuberculosis in high-risk populations. MMWR Morb Mortal Wkly Rep 1995;44(RR-11):19\u201334."},{"key":"10.1016\/j.annder.2010.04.008_bib8","doi-asserted-by":"crossref","unstructured":"Haute Autorit\u00e9 de sant\u00e9. Test de d\u00e9tection de l\u2019interf\u00e9ron \u03b3 pour le diagnostic des infections tuberculeuses. Med Mal Infect 2007;37:689\u201393.","DOI":"10.1016\/j.medmal.2007.05.008"},{"key":"10.1016\/j.annder.2010.04.008_bib9","first-page":"1","article-title":"La place du dosage de l\u2019interf\u00e9ron gamma dans la tuberculose en 2007","volume":"209","author":"Antoun","year":"2007","journal-title":"ORL Pneumo Allergo Pratique"},{"key":"10.1016\/j.annder.2010.04.008_bib10","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.jbspin.2007.09.005","article-title":"Screening for tuberculosis before TNF-alpha antagonist initiation: are current methods good enough?","volume":"75","author":"Bergeron","year":"2008","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.annder.2010.04.008_bib11","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1136\/ard.2007.070789","article-title":"Detection of latent tuberculosis in immunosuppressed patients with autoimmune diseases: performance of a Mycobacterium tuberculosis antigen-specific interferon gamma assay","volume":"67","author":"Matulis","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.annder.2010.04.008_bib12","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1007\/s10096-008-0519-1","article-title":"Performance of two commercial blood IFN-\u03b3 release assays for the detection of Mycobacterium tuberculosis infection in patient candidates for anti-TNF-\u03b1 treatment","volume":"27","author":"Bocchino","year":"2008","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.annder.2010.04.008_bib13","first-page":"776","article-title":"Comparison of an interferon-\u03b3 assay with tuberculin skin testing for detection of tuberculosis (TB) infection in patients with rheumatoid arthritis in a TB-endemic population","volume":"35","author":"Ponce de Leon","year":"2008","journal-title":"J Rheumatol"},{"key":"10.1016\/j.annder.2010.04.008_bib14","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1002\/art.23705","article-title":"Effectiveness of the combination of a whole blood interferon-gamma assay and the tuberculin skin test in detecting latent tuberculosis infection in rheumatoid arthritis patients receiving adalimumab therapy","volume":"59","author":"Chen","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.annder.2010.04.008_bib15","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1007\/s00296-007-0361-2","article-title":"Interferon \u03b3 assay for detecting latent tuberculosis infection in rheumatoid arthritis patients during infliximab administration","volume":"27","author":"Takahashi","year":"2007","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.annder.2010.04.008_bib16","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1164\/rccm.200510-1666ST","article-title":"An official ATS statement: hepatotoxicity of antituberculosis therapy","volume":"174","author":"Saukkonen","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.annder.2010.04.008_bib17","first-page":"1402","article-title":"Detection of latent tuberculosis in patients with psoriasis before antitumour necrosis factor therapy: comparison of in vitro specific blood T-spotTB with tuberculin skin test (Abstract)","volume":"159","author":"Laffitte","year":"2008","journal-title":"Br J Dermatol"}],"container-title":["Annales de Dermatologie et de V\u00e9n\u00e9r\u00e9ologie"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0151963810002139?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0151963810002139?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T10:56:19Z","timestamp":1758970579000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0151963810002139"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,6]]},"references-count":17,"journal-issue":{"issue":"6-7","published-print":{"date-parts":[[2010,6]]}},"alternative-id":["S0151963810002139"],"URL":"https:\/\/doi.org\/10.1016\/j.annder.2010.04.008","relation":{},"ISSN":["0151-9638"],"issn-type":[{"type":"print","value":"0151-9638"}],"subject":[],"published":{"date-parts":[[2010,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pertinence des crit\u00e8res diagnostiques de tuberculose latente avant traitement du psoriasis par anti-TNF-alpha","name":"articletitle","label":"Article Title"},{"value":"Annales de Dermatologie et de V\u00e9n\u00e9r\u00e9ologie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.annder.2010.04.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}